{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:32:45Z","timestamp":1767652365098},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI14C1135"],"award-info":[{"award-number":["HI14C1135"]}]},{"name":"Ministry of Education","award":["2021R1A6A1A03038996"],"award-info":[{"award-number":["2021R1A6A1A03038996"]}]},{"name":"Gachon University Gil Medical Center","award":["FRD2022-16"],"award-info":[{"award-number":["FRD2022-16"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71402-6","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T05:02:12Z","timestamp":1725339732000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Heterogeneity of factors associated with cognitive decline and cortical atrophy in early- versus late-onset Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Jaelim","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy W.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Hyeon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haeun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Ram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Kyu","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel N.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon-Kyung","family":"Seong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"71402_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow, K., de Leon, M. J. & Zetterberg, H. Alzheimer\u2019s disease. The Lancet 368, 387\u2013403 (2006).","journal-title":"The Lancet"},{"key":"71402_CR2","unstructured":"Zhu, X.-C. et al. Rate of early onset Alzheimer\u2019s disease: a systematic review and meta-analysis. Ann. Transl. Med. 3 (2015)."},{"key":"71402_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3233\/JAD-142292","volume":"46","author":"R Migliaccio","year":"2015","unstructured":"Migliaccio, R. et al. Mapping the progression of atrophy in early-and late-onset Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 46, 351\u2013364 (2015).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"71402_CR4","doi-asserted-by":"publisher","first-page":"e1929","DOI":"10.1016\/j.neurobiolaging.2013.01.001","volume":"34","author":"H Cho","year":"2013","unstructured":"Cho, H. et al. Longitudinal changes of cortical thickness in early-versus late-onset Alzheimer\u2019s disease. Neurobiol. Aging 34, e1929\u2013e1921 (2013).","journal-title":"Neurobiol. Aging"},{"key":"71402_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1212\/WNL.46.1.136","volume":"46","author":"E Koss","year":"1996","unstructured":"Koss, E. et al. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer\u2019s disease: A CERAD analysis, Part XII. Neurology 46, 136\u2013141 (1996).","journal-title":"Neurology"},{"key":"71402_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/JAD-2012-111934","volume":"30","author":"LL Smits","year":"2012","unstructured":"Smits, L. L. et al. Early onset Alzheimer\u2019s disease is associated with a distinct neuropsychological profile. J. Alzheimer\u2019s Dis. 30, 101\u2013108 (2012).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"71402_CR7","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/brain\/awx171","volume":"140","author":"M Sch\u00f6ll","year":"2017","unstructured":"Sch\u00f6ll, M. et al. Distinct 18F-AV-1451 tau PET retention patterns in early-and late-onset Alzheimer\u2019s disease. Brain 140, 2286\u20132294 (2017).","journal-title":"Brain"},{"key":"71402_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3233\/JAD-121927","volume":"35","author":"H Cho","year":"2013","unstructured":"Cho, H. et al. Amyloid deposition in early onset versus late onset Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 35, 813\u2013821 (2013).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"71402_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0891988706297086","volume":"20","author":"GA Marshall","year":"2007","unstructured":"Marshall, G. A., Fairbanks, L. A., Tekin, S., Vinters, H. V. & Cummings, J. L. Early-onset Alzheimer\u2019s disease is associated with greater pathologic burden. J. Geriatr. Psychiatry Neurol. 20, 29\u201333 (2007).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"71402_CR10","doi-asserted-by":"publisher","first-page":"606600","DOI":"10.3389\/fnins.2021.606600","volume":"15","author":"WJ Lee","year":"2021","unstructured":"Lee, W. J. et al. Effects of alzheimer\u2019s and vascular pathologies on structural connectivity in early-and late-onset Alzheimer\u2019s disease. Front. Neurosci. 15, 606600 (2021).","journal-title":"Front. Neurosci."},{"key":"71402_CR11","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1038\/ncomms11934","volume":"7","author":"Y Iturria-Medina","year":"2016","unstructured":"Iturria-Medina, Y., Sotero, R. C., Toussaint, P. J., Mateos-P\u00e9rez, J. M. & Evans, A. C. Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat. Commun. 7, 11934 (2016).","journal-title":"Nat. Commun."},{"key":"71402_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1212\/01.wnl.0000172914.08967.dc","volume":"65","author":"J Luchsinger","year":"2005","unstructured":"Luchsinger, J. et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545\u2013551 (2005).","journal-title":"Neurology"},{"key":"71402_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.66.3.343","volume":"66","author":"EP Helzner","year":"2009","unstructured":"Helzner, E. P. et al. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch. Neurol. 66, 343\u2013348 (2009).","journal-title":"Arch. Neurol."},{"key":"71402_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1212\/WNL.0b013e3181b59bf3","volume":"73","author":"Y Deschaintre","year":"2009","unstructured":"Deschaintre, Y., Richard, F., Leys, D. & Pasquier, F. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology 73, 674\u2013680 (2009).","journal-title":"Neurology"},{"key":"71402_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease. Neurology 34, 939\u2013939 (1984).","journal-title":"Neurology"},{"key":"71402_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1552-6569.2008.00292.x","volume":"19","author":"SW Seo","year":"2009","unstructured":"Seo, S. W., Cho, S. S., Park, A., Chin, J. & Na, D. L. Subcortical vascular versus amnestic mild cognitive impairment: Comparison of cerebral glucose metabolism. J. Neuroimaging 19, 213\u2013219 (2009).","journal-title":"J. Neuroimaging"},{"key":"71402_CR17","first-page":"421","volume":"8","author":"F Fazekas","year":"1987","unstructured":"Fazekas, F., Chawluk, J. B., Alavi, A., Hurtig, H. I. & Zimmerman, R. A. MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. Am. J. Neuroradiol. 8, 421\u2013426 (1987).","journal-title":"Am. J. Neuroradiol."},{"key":"71402_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuroimage.2017.07.053","volume":"159","author":"J Chung","year":"2017","unstructured":"Chung, J. et al. Normalization of cortical thickness measurements across different T1 magnetic resonance imaging protocols by novel W-Score standardization. Neuroimage 159, 224\u2013235 (2017).","journal-title":"Neuroimage"},{"key":"71402_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","volume":"132","author":"DN Greve","year":"2016","unstructured":"Greve, D. N. et al. Different partial volume correction methods lead to different conclusions: An 18 F-FDG-PET study of aging. Neuroimage 132, 334\u2013343 (2016).","journal-title":"Neuroimage"},{"key":"71402_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","volume":"92","author":"DN Greve","year":"2014","unstructured":"Greve, D. N. et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. Neuroimage 92, 225\u2013236 (2014).","journal-title":"Neuroimage"},{"key":"71402_CR21","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/brain\/awu064","volume":"137","author":"N Okamura","year":"2014","unstructured":"Okamura, N. et al. Non-invasive assessment of Alzheimer\u2019s disease neurofibrillary pathology using 18F-THK5105 PET. Brain 137, 1762\u20131771 (2014).","journal-title":"Brain"},{"key":"71402_CR22","doi-asserted-by":"publisher","first-page":"e0158460","DOI":"10.1371\/journal.pone.0158460","volume":"11","author":"SN Lockhart","year":"2016","unstructured":"Lockhart, S. N. et al. Dynamic PET measures of tau accumulation in cognitively normal older adults and Alzheimer\u2019s disease patients measured using [18F] THK-5351. PLoS ONE 11, e0158460 (2016).","journal-title":"PLoS ONE"},{"key":"71402_CR23","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2967\/jnumed.114.142109","volume":"55","author":"L Thurfjell","year":"2014","unstructured":"Thurfjell, L. et al. Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: Concordance with visual image reads. J. Nucl. Med. 55, 1623\u20131628 (2014).","journal-title":"J. Nucl. Med."},{"key":"71402_CR24","first-page":"1","volume":"17","author":"U Gr\u00f6mping","year":"2007","unstructured":"Gr\u00f6mping, U. Relative importance for linear regression in R: The package relaimpo. J. Stat. Softw. 17, 1\u201327 (2007).","journal-title":"J. Stat. Softw."},{"key":"71402_CR25","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin, A. et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain 140, 3286\u20133300 (2017).","journal-title":"Brain"},{"key":"71402_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom, G. S. Amyloid-\u03b2 and tau: The trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 71, 505\u2013508 (2014).","journal-title":"JAMA Neurol."},{"key":"71402_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack","year":"2016","unstructured":"Jack, C. R. et al. A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539\u2013547 (2016).","journal-title":"Neurology"},{"key":"71402_CR28","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.neurobiolaging.2014.03.009","volume":"35","author":"E Cavedo","year":"2014","unstructured":"Cavedo, E. et al. Medial temporal atrophy in early and late-onset Alzheimer\u2019s disease. Neurobiol. Aging 35, 2004\u20132012 (2014).","journal-title":"Neurobiol. Aging"},{"key":"71402_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ana.25399","volume":"85","author":"JS Rabin","year":"2019","unstructured":"Rabin, J. S. et al. Vascular risk and \u03b2-amyloid are synergistically associated with cortical tau. Ann. Neurol. 85, 272\u2013279 (2019).","journal-title":"Ann. Neurol."},{"key":"71402_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1749-6632.2002.tb04807.x","volume":"977","author":"AD Korczyn","year":"2002","unstructured":"Korczyn, A. D. Mixed dementia\u2014the most common cause of dementia. Ann. N. Y. Acad. Sci. 977, 129\u2013134 (2002).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"71402_CR31","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider, J. A., Arvanitakis, Z., Bang, W. & Bennett, D. A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197\u20132204 (2007).","journal-title":"Neurology"},{"key":"71402_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ana.21142","volume":"62","author":"JA Schneider","year":"2007","unstructured":"Schneider, J. A., Boyle, P. A., Arvanitakis, Z., Bienias, J. L. & Bennett, D. A. Subcortical infarcts, Alzheimer\u2019s disease pathology, and memory function in older persons. Ann. Neurol. 62, 59\u201366 (2007).","journal-title":"Ann. Neurol."},{"key":"71402_CR33","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1017\/S0317167100015547","volume":"39","author":"K Honjo","year":"2012","unstructured":"Honjo, K., Black, S. E. & Verhoeff, N. P. Alzheimer\u2019s disease, cerebrovascular disease, and the \u03b2-amyloid cascade. Can. J. Neurol. Sci. 39, 712\u2013728 (2012).","journal-title":"Can. J. Neurol. Sci."},{"key":"71402_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11011-021-00814-4","volume":"37","author":"R Ap\u00e1tiga-P\u00e9rez","year":"2022","unstructured":"Ap\u00e1tiga-P\u00e9rez, R. et al. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer\u2019s disease. Metab. Brain Dis. 37, 39\u201350 (2022).","journal-title":"Metab. Brain Dis."},{"key":"71402_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1750-3639.2006.tb00559.x","volume":"16","author":"SX Zhang-Nunes","year":"2006","unstructured":"Zhang-Nunes, S. X. et al. The cerebral \u03b2-amyloid angiopathies: Hereditary and sporadic. Brain Pathol. 16, 30\u201339 (2006).","journal-title":"Brain Pathol."},{"key":"71402_CR36","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1091\/mbc.e12-12-0858","volume":"24","author":"EM Ramser","year":"2013","unstructured":"Ramser, E. M. et al. Amyloid-\u03b2 oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons. Mol. Biol. Cell 24, 2494\u20132505 (2013).","journal-title":"Mol. Biol. Cell"},{"key":"71402_CR37","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.neurobiolaging.2010.12.003","volume":"33","author":"SW Seo","year":"2012","unstructured":"Seo, S. W. et al. Cortical thinning related to periventricular and deep white matter hyperintensities. Neurobiol. Aging 33, 1156\u20131167 (2012).","journal-title":"Neurobiol. Aging"},{"key":"71402_CR38","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1161\/01.STR.0000179092.59909.42","volume":"36","author":"WM van der Flier","year":"2005","unstructured":"van der Flier, W. M. et al. Small vessel disease and general cognitive function in nondisabled elderly: The LADIS study. Stroke 36, 2116\u20132120 (2005).","journal-title":"Stroke"},{"key":"71402_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2023","unstructured":"Van Dyck, C. H. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"71402_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0227-5","volume":"9","author":"KP Ng","year":"2017","unstructured":"Ng, K. P. et al. Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain. Alzheimer\u2019s Res. Ther. 9, 1\u20139 (2017).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"71402_CR41","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/ijms24043754","volume":"24","author":"J Andrade-Guerrero","year":"2023","unstructured":"Andrade-Guerrero, J. et al. Alzheimer\u2019s disease: An updated overview of its genetics. Int. J. Mol. Sci. 24, 3754 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"71402_CR42","doi-asserted-by":"crossref","unstructured":"Andrews, S. J. et al. The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. EBioMed. 90 (2023).","DOI":"10.1016\/j.ebiom.2023.104511"},{"key":"71402_CR43","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41398-021-01677-0","volume":"11","author":"H-H Chen","year":"2021","unstructured":"Chen, H.-H. et al. Genetically regulated expression in late-onset Alzheimer\u2019s disease implicates risk genes within known and novel loci. Transl. Psychiatry 11, 618 (2021).","journal-title":"Transl. Psychiatry"},{"key":"71402_CR44","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","volume":"6","author":"C Reitz","year":"2020","unstructured":"Reitz, C., Rogaeva, E. & Beecham, G. W. Late-onset vs nonmendelian early-onset Alzheimer disease: A distinction without a difference?. Neurol. Genet. 6, e512 (2020).","journal-title":"Neurol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71402-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71402-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71402-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T06:06:34Z","timestamp":1725343594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71402-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71402"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71402-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"assertion":[{"value":"7 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all participants and the study was approved by Institutional Review Board of Gachon University Gil Medical Center (IRB No: GDIRB2015-272).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"20429"}}